EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case T-448/25: Action brought on 8 July 2025 – Arkema France and Miwon Europe v ECHA

ECLI:EU:UNKNOWN:62025TN0448

62025TN0448

July 8, 2025
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

Official Journal of the European Union

EN

C series

C/2025/4637

(Case T-448/25)

(C/2025/4637)

Language of the case: English

Parties

Applicants: Arkema France (Puteaux, France), Miwon Europe GmbH (Mainz, Germany) (represented by: R. Cana and E. Mullier, lawyers)

Defendant: European Chemicals Agency

Form of order sought

The applicants claim that the Court should:

Declare the application admissible and well founded;

Annul the decision of the Board of Appeal of the European Chemicals Agency A-003-2024 of 29 April 2025 (‘the Contested Decision’) in its entirety;

Take measures such that 2024 Decision is devoid of effects, to allow for an effective remedy for the applicants;

Order the defendant to pay the costs of these proceedings; and

Take such other or further measure as justice may require.

Pleas in law and main arguments

In support of the action, the applicants rely on five pleas in law.

1.First plea in law, alleging that the defendant had breached Article 93(1) of REACH Regulation by adopting a new, separate 2024 Decision in the context of the rectification procedure, and breached the principle of legal certainty.

2.Second plea in law, alleging that the defendant had breached Article 41 and Article 42(1) of the REACH Regulation, and exceeded its competence under these provisions.

3.Third plea in law, alleging that the defendant had breached Article 42 of REACH Regulation and exceeded its competence because it concluded the dossier non-compliant on the basis of considerations that go beyond the standard requirements of the relevant REACH Annex.

4.Fourth plea in law, alleging that the defendant had committed a manifest error of assessment and failed to take all relevant information into account by concluding that (i) the dose level selection in the one-generation reproductive toxicity study (‘EOGRTS’) was inadequate; and (ii) the immunotoxicity assay (‘TDAR assay’) was unreliable, rendering the EOGRTS non-compliant.

5.Fifth plea in law, alleging that the defendant had breached the principle of proportionality, the principle of legal certainty and Article 25 of REACH Regulation by not considering other means to fulfil the alleged data gap, and by failing to allow the applicants to comply with the defendant’s request by submitting an adaptation under Annex XI of REACH Regulation.

ELI: http://data.europa.eu/eli/C/2025/4637/oj

ISSN 1977-091X (electronic edition)

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia